SEC Form 3 · accession 0001209191-15-039670
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurent Fischer
Officer — Chief Executive Officer · Director
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 8:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | — | holding | — | — | — | — | — | Common Stock | 0 | — | D |
Explanation of responses
- F1The Reporting Person holds no shares of Issuer.
- F2Reporting Person holds no Derivative Securities of the Issuer.